Domingo Rocha
Family Medicine · Hampstead, MDNPI 1760490023
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 27.8% of the total. Reporting peaked in 2020 at $1,121 and has fallen 98.7% since, to $14 in 2024.
Across 205 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$839
- AstraZeneca$550
- Johnson & Johnson$213
- Lilly USA, LLC$168
- Merck$147
- GSK$121
- plus $981 from 23 others
What the payments were for
- Food & beverage$3,007100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 70 | $839 |
| AstraZeneca | 33 | $550 |
| Johnson & Johnson | 10 | $213 |
| Lilly USA, LLC | 12 | $168 |
| Merck | 11 | $147 |
| GSK | 8 | $121 |
| Novo Nordisk | 7 | $109 |
| Pfizer | 6 | $89 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $88 |
| Cranial Technologies, Inc | 6 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $80 |
| Supernus Pharmaceuticals, Inc. | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 2 | $51 |
| Eisai Inc. | 3 | $50 |
| Amgen(2 entities) | 3 | $46 |
| Biohaven Pharmaceuticals, Inc. | 3 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $40 |
| Novartis | 2 | $36 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Astellas Pharma US Inc | 2 | $28 |
| Jazz Pharmaceuticals Inc. | 2 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Medtronic | 1 | $15 |
| Gilead | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Amryt Pharma Holdings Ltd | 1 | $14 |
| Neos Therapeutics, LP | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$109
How this compares
$3,019 in reported general payments places this provider in the 80th percentile of 1,193 family medicine providers in Maryland.
Other family medicine in Hampstead
- Karen DonaldsonBaltimore$899K
- Louis JacquesBaltimore$522K
- Michael ObiefuneBaltimore$291K
- Thomas LawrenceBerlin$254K
- Casey ScottCambridge$88K
- Daljeet SalujaBaltimore$63K
- Sanjay SaxenaHagerstown$60K
- Cynthia KleppingerSilver Spring$51K
- Tramaine DavisBowie$43K
- Alkesh PatelColumbia$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.